Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.5K
The Sarcomere01:08

The Sarcomere

17.1K
A sarcomere is a microscopic segment repeating in a myofibril. The sarcomere fundamentally consists of two main myofilaments: thick filaments called myosin and thin filaments called actin. These filaments interact by sliding past each other in response to stimulus. In addition to myosin and actin, several other proteins, such as tropomyosin, troponin, titin, nebulin, myomesin, α-actinin, and dystrophin, play crucial roles in regulating, structuring, and functioning of the sarcomere.
Each...
17.1K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

15.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.0K
Cancer Therapies02:49

Cancer Therapies

10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Skin Cancer01:30

Skin Cancer

6.3K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.3K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Machine Learning-Guided Survival Prediction and Treatment Sequencing in Advanced Soft Tissue Sarcoma Beyond Second-Line Therapy: A Retrospective Cohort Study.

Oncology and therapy·2026
Same author

Response to Letter to the Editor: Comments on "Surgery for Retroperitoneal Soft Tissue is Safe following Multimodal Treatment with Regional Hyperthermia".

Annals of surgical oncology·2026
Same author

Neoadjuvant chemotherapy for soft-tissue sarcoma of the extremities: A post-hoc Sarculator-based risk analysis of the EORTC 62961-ESHO 95 randomized trial.

Cancer·2026
Same author

Initial Clinical Experience with [<sup>177</sup>Lu]Lu-RTX-2358 Radiopharmaceutical Therapy Targeting Fibroblast Activation Protein: Biodistribution, Pharmacokinetics, and Dosimetry.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Blinatumomab in Combined Immune Thrombocytopenia and Antiphospholipid Syndrome.

The New England journal of medicine·2026
Same author

Evaluation of RECIST v1.1 for predicting overall survival in sarcoma patients with pulmonary metastasis.

Cancer imaging : the official publication of the International Cancer Imaging Society·2026
Same journal

[Digital patient journey after radiological diagnostics : Patient portals-what comes after the examination?]

Radiologie (Heidelberg, Germany)·2026
Same journal

[Before the examination: digital check-in].

Radiologie (Heidelberg, Germany)·2026
Same journal

[National infrastructures and the European Health Data Space].

Radiologie (Heidelberg, Germany)·2026
Same journal

[The digital patient journey : Performing radiological examinations].

Radiologie (Heidelberg, Germany)·2026
Same journal

Radiologie (Heidelberg, Germany)·2026
Same journal

Radiologie (Heidelberg, Germany)·2026
Ver todos los artículos relacionados

Video Experimental Relacionado

Updated: Feb 24, 2026

The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

26.4K

Sarcomas: Introducción clínica

Lars H Lindner1

  • 1Zentrum für Knochen- und Weichteiltumoren (SarKUM), LMU Klinikum, Medizinische Klinik III, Marchioninistr. 15, 81377, München, Deutschland. lars.lindner@med.uni-muenchen.de.

Radiologie (Heidelberg, Germany)
|February 23, 2026
PubMed
Resumen
Este resumen es generado por máquina.

El diagnóstico radiológico es crucial para la planificación del tratamiento del sarcoma. La interpretación precisa de las imágenes, incluida la resonancia magnética de cuerpo entero, ayuda a detectar metástasis y evaluar la respuesta al tratamiento, garantizando la seguridad oncológica y minimizando la exposición a la radiación.

Palabras clave:
Atención multidisciplinariaTerapia neoadyuvantePseudoprogresiónImagenología de sarcomasResonancia magnética de cuerpo entero

Más Videos Relacionados

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.7K
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

15.3K

Videos de Experimentos Relacionados

Last Updated: Feb 24, 2026

The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

26.4K
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.7K
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

15.3K

Área de la Ciencia:

  • Oncología
  • Radiología
  • Imagenología Médica

Sus antecedentes:

  • Los sarcomas son tumores malignos heterogéneos de los tejidos conectivos.
  • La experiencia radiológica especializada es vital para un diagnóstico y una planificación del tratamiento precisos.
  • Los radiólogos identifican hallazgos sospechosos y facilitan la derivación a centros especializados.

Objetivo del estudio:

  • Destacar el papel fundamental del diagnóstico radiológico en el manejo del sarcoma.
  • Enfatizar la necesidad de estrategias de imagen personalizadas basadas en el subtipo de sarcoma.
  • Abordar los desafíos en la evaluación de la respuesta al tratamiento y durante el seguimiento.

Principales métodos:

  • Revisión de estrategias de imagen para varios subtipos de sarcoma.
  • Discusión de la resonancia magnética de cuerpo entero para la detección de metástasis óseas (por ejemplo, liposarcoma mixoide).
  • Análisis de los desafíos para diferenciar la pseudoprogresión de la progresión real en entornos neoadyuvantes.

Principales resultados:

  • La interpretación precisa de las imágenes es el primer paso en la planificación del tratamiento del sarcoma.
  • Las estrategias de imagen personalizadas, como la resonancia magnética de cuerpo entero, son esenciales para subtipos específicos.
  • Distinguir los cambios relacionados con el tratamiento de la progresión tumoral es un desafío clave.

Conclusiones:

  • Los radiólogos son fundamentales en la detección temprana, la derivación y la planificación del tratamiento de los sarcomas.
  • Las estrategias de imagen apropiadas dependen del subtipo y son cruciales para un manejo eficaz.
  • Equilibrar la seguridad oncológica con la exposición a la radiación es primordial en el seguimiento del sarcoma.